Eventide Asset Management - ALDER BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$1,643,000
-63.3%
79,000
-63.3%
0.11%
-62.5%
Q4 2016$4,472,000215,0000.29%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,585,683$51,963,00024.29%
Foresite Capital Management II, LLC 802,724$26,305,00012.56%
Cormorant Asset Management, LP 1,689,071$55,351,0006.10%
New Leaf Venture Partners, L.L.C. 230,954$7,568,0005.45%
DAFNA Capital Management LLC 165,313$5,417,0003.77%
SENZAR ASSET MANAGEMENT, LLC 296,670$9,721,876,0002.51%
Partner Investment Management, L.P. 41,960$1,375,0002.04%
BB BIOTECH AG 1,685,150$55,222,0001.94%
PFM Health Sciences, LP 2,007,664$65,791,0001.93%
Redmile Group, LLC 702,539$23,022,0001.83%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders